Lakefront Biotherapeutics holder tops 5% stake
Lakefront Biotherapeutics reported that Madison Avenue Partners and its affiliates have become a significant shareholder under Belgian transparency rules.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
6-K
Rhea-AI Filing Summary
Lakefront Biotherapeutics reported that Madison Avenue Partners and its affiliates have become a significant shareholder under Belgian transparency rules. Madison Avenue Partners crossed the 5% voting rights threshold on June 15, 2026, following acquisitions of Lakefront voting securities.
As of June 24, 2026, Madison Avenue Partners and its affiliates held 3,498,892 voting rights, representing 5.31% of Lakefront’s 65,897,071 currently outstanding shares. The notification confirms there are no equivalent financial instruments linked to this position.
Key Figures
Voting rights held: 3,498,892 voting rights
Ownership percentage: 5.31% of voting rights
Shares outstanding: 65,897,071 shares
+4 more
7 metrics
Voting rights held
3,498,892 voting rights
Held by Madison Avenue Partners group as of June 24, 2026
Ownership percentage
5.31% of voting rights
Stake in Lakefront based on current outstanding shares
Shares outstanding
65,897,071 shares
Denominator used to calculate voting rights percentage
Transparency threshold
5% of voting rights
Belgian major shareholding disclosure trigger crossed June 15, 2026
Date threshold crossed
June 15, 2026
Date Madison Avenue Partners exceeded 5% voting rights
Notification date
June 24, 2026
Date of transparency notification from Madison Avenue Partners
Equivalent financial instruments
0 voting rights, 0.00%
No additional exposure via financial instruments after transaction
Key Terms
transparency notification, voting rights, equivalent financial instruments, denominator, +1 more
5 terms
transparency notification regulatory
"Lakefront Biotherapeutics NV ... received a transparency notification from Madison Avenue Partners."
A transparency notification is a public alert required by market rules when a shareholder’s stake in a listed company rises above or falls below specified levels of ownership. It tells investors who is gaining or losing influence — like seeing someone start to buy or sell large slices of a cake — and matters because such moves can signal changes in control, voting power, potential alliances or takeover interest, which can affect share value and investor decisions.
voting rights financial
"crossed above the threshold of 5% of Lakefront’ voting rights on an aggregated basis"
Voting rights are the ability of shareholders to have a say in important company decisions, like choosing leaders or approving big changes. They matter because they give owners a voice in how the company is run, similar to how voters influence elections, ensuring the company acts in shareholders’ interests.
equivalent financial instruments financial
"Equivalent financial instruments after the transaction"
Financial assets or contracts that provide the same or very similar economic exposure, risks, and returns as one another, such as two ways to gain the same market exposure through different products. For investors this matters because choosing between equivalents is often about cost, convenience, tax treatment or counterparty risk—like picking between two routes that get you to the same destination but differ in tolls, travel time and safety. Recognizing equivalents helps compare options and manage portfolio risk efficiently.
denominator financial
"Denominator 65,897,071"
The denominator is the number on the bottom of a fraction that shows the total population or base used to calculate a rate, percentage or ratio — for example, the total shares outstanding when calculating earnings per share, or all trial participants when reporting a safety rate. It matters to investors because changing the denominator (by issuing more shares, changing the population measured, or narrowing the base) can make percentages and per‑unit figures look better or worse even if the underlying raw numbers stay the same, much like changing the size of a pizza makes each slice appear larger or smaller.
threshold of voting rights regulatory
"Threshold of voting rights crossed (in %): 5%"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Lakefront Biotherapeutics (LKFT) disclose in this Form 6-K?
Lakefront Biotherapeutics disclosed that Madison Avenue Partners and affiliates crossed the 5% voting rights threshold. The group now holds 3,498,892 voting rights, or 5.31% of Lakefront’s 65,897,071 outstanding shares, triggering a mandatory transparency notification under Belgian law.
How large is Madison Avenue Partners’ stake in Lakefront Biotherapeutics (LKFT)?
Madison Avenue Partners and its affiliates reported holding 3,498,892 voting rights in Lakefront. This position represents 5.31% of Lakefront’s currently outstanding 65,897,071 shares, making the group a significant shareholder under Belgian transparency legislation requiring disclosure above the 5% threshold.
When did Madison Avenue Partners cross the 5% threshold in LKFT voting rights?
Madison Avenue Partners crossed the 5% voting rights threshold in Lakefront Biotherapeutics on June 15, 2026. The transparency notification was dated June 24, 2026, and reported that the group held 5.31% of the company’s voting rights as of that date.
Does Madison Avenue Partners hold equivalent financial instruments in Lakefront Biotherapeutics (LKFT)?
The notification states that Madison Avenue Partners and its affiliates do not hold any equivalent financial instruments in Lakefront. After the transaction, the table for equivalent financial instruments shows zero voting rights and 0.00% of voting rights attributable to such instruments.
Does this Lakefront Biotherapeutics (LKFT) filing include earnings or financial results?
The filing focuses on a transparency notification about a major shareholding by Madison Avenue Partners. It details voting rights, percentages, and dates related to the 5% threshold crossing, but does not present earnings figures or broader financial performance information.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates